Randomised, double-blind, placebo-controlled, cross-over study to examine the effects of tiotropium on lung hyperinflation, respiratory mechanics and dyspnea during exercise in patients with COPD [chronic obstructive pulmonary disease]

Trial Profile

Randomised, double-blind, placebo-controlled, cross-over study to examine the effects of tiotropium on lung hyperinflation, respiratory mechanics and dyspnea during exercise in patients with COPD [chronic obstructive pulmonary disease]

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2007

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Pharmacodynamics; Therapeutic Use
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 01 Sep 2007 Results have been published
    • 28 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top